Multiplicity of fibronectin-binding alpha V integrin receptors in colorectal cancer. 1996

M V Agrez, and R C Bates, and D Mitchell, and N Wilson, and N Ferguson, and P Anseline, and D Sheppard
Discipline of Surgical Science, Cancer Research Unit, John Hunter Hospital, Newcastle, Australia.

Current data from in vitro and in vivo animal models indicate that fibronectin-binding integrin receptors expressed by colon cancer cells may regulate tumour growth. While individual members of the beta 1 subfamily of integrins have now been clearly identified in colorectal cancer, little information exists with respect to the alpha V subfamily. In the present study we show that alpha V can associate with multiple and different beta subunits capable of binding fibronectin in this tumour type. This is likely to have functional implications for growth and spread of colorectal cancer.

UI MeSH Term Description Entries
D011233 Precipitin Tests Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate. Precipitin Test,Test, Precipitin,Tests, Precipitin
D005353 Fibronectins Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins. Cold-Insoluble Globulins,LETS Proteins,Fibronectin,Opsonic Glycoprotein,Opsonic alpha(2)SB Glycoprotein,alpha 2-Surface Binding Glycoprotein,Cold Insoluble Globulins,Globulins, Cold-Insoluble,Glycoprotein, Opsonic,Proteins, LETS,alpha 2 Surface Binding Glycoprotein
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D015703 Antigens, CD Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation. CD Antigen,Cluster of Differentiation Antigen,Cluster of Differentiation Marker,Differentiation Antigens, Leukocyte, Human,Leukocyte Differentiation Antigens, Human,Cluster of Differentiation Antigens,Cluster of Differentiation Markers,Antigen Cluster, Differentiation,Antigen, CD,CD Antigens,Differentiation Antigen Cluster,Differentiation Marker Cluster,Marker Cluster, Differentiation
D017469 Receptors, Fibronectin Specific cell surface receptors which bind to FIBRONECTINS. Studies have shown that these receptors function in certain types of adhesive contact as well as playing a major role in matrix assembly. These receptors include the traditional fibronectin receptor, also called INTEGRIN ALPHA5BETA1 and several other integrins. Fibronectin Receptors
D039564 Integrin alphaV An alpha integrin with a molecular weight of 160-kDa that is found in a variety of cell types. It undergoes posttranslational cleavage into a heavy and a light chain that are connected by disulfide bonds. Integrin alphaV can combine with several different beta subunits to form heterodimers that generally bind to RGD sequence-containing extracellular matrix proteins. Antigens, CD51,CD51 Antigens,CD51 Antigen,Integrin alpha V,alpha(V) Integrin,alphav Integrin,Antigen, CD51,Integrin, alphav,alpha V, Integrin,alphaV, Integrin

Related Publications

M V Agrez, and R C Bates, and D Mitchell, and N Wilson, and N Ferguson, and P Anseline, and D Sheppard
March 1992, The Journal of biological chemistry,
M V Agrez, and R C Bates, and D Mitchell, and N Wilson, and N Ferguson, and P Anseline, and D Sheppard
January 1999, Advances in cancer research,
M V Agrez, and R C Bates, and D Mitchell, and N Wilson, and N Ferguson, and P Anseline, and D Sheppard
August 2001, The Journal of biological chemistry,
M V Agrez, and R C Bates, and D Mitchell, and N Wilson, and N Ferguson, and P Anseline, and D Sheppard
January 2003, Hepato-gastroenterology,
M V Agrez, and R C Bates, and D Mitchell, and N Wilson, and N Ferguson, and P Anseline, and D Sheppard
June 2003, Current opinion in investigational drugs (London, England : 2000),
M V Agrez, and R C Bates, and D Mitchell, and N Wilson, and N Ferguson, and P Anseline, and D Sheppard
January 1994, International immunology,
M V Agrez, and R C Bates, and D Mitchell, and N Wilson, and N Ferguson, and P Anseline, and D Sheppard
January 2001, Blood,
M V Agrez, and R C Bates, and D Mitchell, and N Wilson, and N Ferguson, and P Anseline, and D Sheppard
June 1995, British journal of cancer,
M V Agrez, and R C Bates, and D Mitchell, and N Wilson, and N Ferguson, and P Anseline, and D Sheppard
January 2008, Drug development research,
M V Agrez, and R C Bates, and D Mitchell, and N Wilson, and N Ferguson, and P Anseline, and D Sheppard
September 1996, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
Copied contents to your clipboard!